Search by Drug Name or NDC
NDC 60687-0679-21 Bisoprolol Fumarate 5 mg/1 Details
Bisoprolol Fumarate 5 mg/1
Bisoprolol Fumarate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is BISOPROLOL FUMARATE.
MedlinePlus Drug Summary
Bisoprolol is used alone or in combination with other medications to treat high blood pressure. Bisoprolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 60687-0679-21Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bisoprolol
Product Information
| NDC | 60687-0679 |
|---|---|
| Product ID | 60687-679_f663d526-98fe-4fff-e053-2995a90a31f4 |
| Associated GPIs | |
| GCN Sequence Number | 017956 |
| GCN Sequence Number Description | bisoprolol fumarate TABLET 5 MG ORAL |
| HIC3 | J7C |
| HIC3 Description | BETA-ADRENERGIC BLOCKING AGENTS |
| GCN | 63821 |
| HICL Sequence Number | 007396 |
| HICL Sequence Number Description | BISOPROLOL FUMARATE |
| Brand/Generic | Generic |
| Proprietary Name | Bisoprolol Fumarate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bisoprolol fumarate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | BISOPROLOL FUMARATE |
| Labeler Name | American Health Packaging |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078635 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60687-0679-21 (60687067921)
| NDC Package Code | 60687-679-21 |
|---|---|
| Billing NDC | 60687067921 |
| Package | 30 BLISTER PACK in 1 CARTON (60687-679-21) / 1 TABLET in 1 BLISTER PACK (60687-679-11) |
| Marketing Start Date | 2023-04-20 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.28138 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BISOPROLOL FUMARATE 5 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |